Silexion Therapeutics Corp (SLXNW) Operating cash flow 2023–2025
Silexion Therapeutics Corp (SLXNW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.8MFY2025 · since FY2023: -$4.5M → -$10.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.8M | -28.9% |
| FY2024 | -$8.4M | -85.4% |
| FY2023 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SLXNW financial trends
SLXNW RevenueSLXNW Net incomeSLXNW Net marginSLXNW Gross profitSLXNW Gross marginSLXNW Operating incomeSLXNW Operating marginSLXNW Free cash flowSLXNW Capital expendituresSLXNW Return on equitySLXNW Stock buybacksSLXNW Dividends paidSLXNW Total assetsSLXNW Total liabilitiesSLXNW Shareholders’ equitySLXNW overview →